2019: Phylogica Limited trading as PYC Therapeutics (ASX: PYC) ‘The Company’ or ‘PYC’ is pleased to announce the appointment of Dr. Fred K Chen to PYC’s Scientific Advisory Board (SAB). In addition to joining the SAB, Dr. Chen will also be the founding member of PYC’s Opthalmology Clinical Advisory Board – a specialist advisory board with the objective of guiding PYC’s ophthalmology pipeline through clinical evaluation.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.060(4.62%) |
Mkt cap ! $726.1M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $164.3K | 132.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27970 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4446 | 4 |
View Market Depth
| Last trade - 15.50pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |